These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35216189)

  • 1. DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma.
    Kao CC; Chang YL; Liu HY; Wu ST; Meng E; Cha TL; Sun GH; Yu DS; Luo HL
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
    Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
    J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma.
    Luo HL; Chiang PH; Huang CC; Su YL; Sung MT; Tsai EM; Lin CS; Chiang PH
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis.
    Fujimoto M; Arai E; Tsumura K; Yotani T; Yamada Y; Takahashi Y; Maeshima AM; Fujimoto H; Yoshida T; Kanai Y
    Epigenetics; 2020 Dec; 15(12):1289-1301. PubMed ID: 32498593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
    World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A global profile of gene promoter methylation in treatment-naïve urothelial cancer.
    Ibragimova I; Dulaimi E; Slifker MJ; Chen DY; Uzzo RG; Cairns P
    Epigenetics; 2014 May; 9(5):760-73. PubMed ID: 24521710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
    Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
    Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methylation status of RASSF1A gene promoter in upper tract urothelial carcinoma and its clinical significance].
    Liu J; Xiong GY; Tang Q; Fang D; Li XS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):571-578. PubMed ID: 29263491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing.
    Zhang Q; Wang C; Qin M; Ye Y; Mo Y; Meng Q; Yang G; Feng G; Lin R; Xian S; Wei J; Chen S; Wang S; Mo Z
    Front Immunol; 2024; 15():1298087. PubMed ID: 38903524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma.
    Liang PI; Wei YC; Chen HD; Ma YC; Ke HL; Chien CC; Chuang HW
    Kaohsiung J Med Sci; 2024 Mar; 40(3):269-279. PubMed ID: 38180299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder.
    Tripathi K; Goel A; Singhai A; Garg M
    Mol Biol Rep; 2021 Mar; 48(3):2183-2199. PubMed ID: 33620658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract.
    Lee HY; Yeh BW; Chan TC; Yang KF; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Liang PI; Shiue YL; Wu WJ; Li CF
    Oncotarget; 2017 Jul; 8(29):47216-47229. PubMed ID: 28525382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.
    Monteiro-Reis S; Leça L; Almeida M; Antunes L; Monteiro P; Dias PC; Morais A; Oliveira J; Henrique R; Jerónimo C
    Eur J Cancer; 2014 Jan; 50(1):226-33. PubMed ID: 24100025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
    Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
    Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
    Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N
    Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
    Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
    J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis.
    Erichsen L; Ghanjati F; Beermann A; Poyet C; Hermanns T; Schulz WA; Seifert HH; Wild PJ; Buser L; Kröning A; Braunstein S; Anlauf M; Jankowiak S; Hassan M; Bendhack ML; Araúzo-Bravo MJ; Santourlidis S
    Sci Rep; 2018 Feb; 8(1):3477. PubMed ID: 29472622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma.
    Luo HL; Liu HY; Chang YL; Sung MT; Chen PY; Su YL; Huang CC; Peng JM
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.